These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 33708893)
21. Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy. Haladyna JN; Pastuer T; Riedel SS; Perraud AL; Bernt KM Exp Hematol; 2016 Jul; 44(7):596-602.e3. PubMed ID: 27033163 [TBL] [Abstract][Full Text] [Related]
22. Relationships between AML1-ETO and MLL-AF9 fusion gene expressions and hematological parameters in acute myeloid leukemia. Muddathir ARM; Hamid TAM; Mohamed Elamin E; Khabour OF Gulf J Oncolog; 2020 Sep; 1(34):65-69. PubMed ID: 33431365 [TBL] [Abstract][Full Text] [Related]
23. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis. Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232 [TBL] [Abstract][Full Text] [Related]
24. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia. Gao Y; Gao J; Li M; Zheng Y; Wang Y; Zhang H; Wang W; Chu Y; Wang X; Xu M; Cheng T; Ju Z; Yuan W J Hematol Oncol; 2016 Apr; 9():36. PubMed ID: 27071307 [TBL] [Abstract][Full Text] [Related]
25. The incidence and distribution characteristics of MLL rearrangements in Chinese acute myeloid leukemia patients by multiplex nested RT-PCR. Yang H; Cao T; Gao L; Wang L; Zhu C; Xu Y; Jing Y; Zhu H; Lv N; Yu L Technol Health Care; 2017 Jul; 25(S1):259. PubMed ID: 28582914 [TBL] [Abstract][Full Text] [Related]
26. Heterogeneous effects of M-CSF isoforms on the progression of MLL-AF9 leukemia. Wang R; Feng W; Yang F; Yang X; Wang L; Chen C; Hu Y; Ren Q; Zheng G Immunol Cell Biol; 2018 Feb; 96(2):190-203. PubMed ID: 29363207 [TBL] [Abstract][Full Text] [Related]
31. Frequency of 11q23/MLL gene rearrangement in Egyptian childhood acute myeloblastic leukemia: Biologic and clinical significance. Hagag AA; Shebl SS; El-Fadaly NH South Asian J Cancer; 2014 Oct; 3(4):206-8. PubMed ID: 25422805 [TBL] [Abstract][Full Text] [Related]
32. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia. Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381 [TBL] [Abstract][Full Text] [Related]
33. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia. Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727 [TBL] [Abstract][Full Text] [Related]
34. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia. Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911 [TBL] [Abstract][Full Text] [Related]
35. [Establishment of the retrovirus-mediated murine model with MLL-AF9 leukemia]. Xu SM; Yang Y; Zhou M; Zhao XJ; Qin Y; Zhang PL; Yuan RF; Zhou JF; Fang Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1126-32. PubMed ID: 24156419 [TBL] [Abstract][Full Text] [Related]
36. Liu J; Guo B; Chen Z; Wang N; Iacovino M; Cheng J; Roden C; Pan W; Khan S; Chen S; Kyba M; Fan R; Guo S; Lu J Blood; 2017 Mar; 129(11):1491-1502. PubMed ID: 28053194 [TBL] [Abstract][Full Text] [Related]
37. Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Wei J; Wunderlich M; Fox C; Alvarez S; Cigudosa JC; Wilhelm JS; Zheng Y; Cancelas JA; Gu Y; Jansen M; Dimartino JF; Mulloy JC Cancer Cell; 2008 Jun; 13(6):483-95. PubMed ID: 18538732 [TBL] [Abstract][Full Text] [Related]
38. Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia. Matsuo H; Iijima-Yamashita Y; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K Pediatr Int; 2018 Jan; 60(1):41-46. PubMed ID: 29067751 [TBL] [Abstract][Full Text] [Related]
39. The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment. Lin S; Luo RT; Shrestha M; Thirman MJ; Mulloy JC Blood; 2017 Aug; 130(7):903-907. PubMed ID: 28637661 [TBL] [Abstract][Full Text] [Related]
40. Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice. Bilardi RA; Anstee NS; Glaser SP; Robati M; Vandenberg CJ; Cory S Cell Death Dis; 2016 Sep; 7(9):e2351. PubMed ID: 27584789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]